Glaucoma, Open-Angle Clinical Trial
Official title:
How Does the visuALL Field Analyzer (vFA) Compare to Standard Automatic Perimetry (SAP) in Patients With Mild and Moderate Chronic Open Angle Glaucoma (COAG) and Subjects Without Eye Problems?
Verified date | June 2022 |
Source | Wills Eye |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine age-adjusted reference values of the visuALL Field Analyzer (vFA) retinal sensitivity and to assess the repeatability of the measured values and compare them with those measured by a Standard Automatic Perimetry (SAP).
Status | Completed |
Enrollment | 72 |
Est. completion date | October 20, 2020 |
Est. primary completion date | October 20, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 80 Years |
Eligibility | Inclusion Criteria: - age 21 to 80 years - Healthy subjects with no eye diseases, normal appearing optic nerve and retina, intraocular pressure less than 19 millimeters mercury and normal standard automatic perimetry (SAP). - mild glaucoma subjects with less than -6 mean deviation - moderate glaucoma subjects with -6 to -12 mean deviation Exclusion Criteria: - spherical refraction outside ± 3.0 diopters and cylinder correction outside 2.0 diopters - Unreliable SAP (false positives, fixation losses and false negatives greater than 25% and/or observable testing artifacts) - Unreliable visuALL Field Analyzer (vFA) (greater than 25% false positive, excessive fixation losses) - SAP abnormality with pattern loss consistent with neurologic and/or other ocular diseases than glaucoma - Intraocular surgery in study eye (except non-complicated cataract or refractive surgery performed more than 6 months before enrollment and without posterior capsule opacification) - History of systemic condition known to affect visual function - History of medication known to affect visual function |
Country | Name | City | State |
---|---|---|---|
United States | Wills Eye Hospital | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Wills Eye | Olleyes, Inc. |
United States,
Razeghinejad R, Gonzalez-Garcia A, Myers JS, Katz LJ. Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry. J Glaucoma. 2021 Jan 1;30(1):17-23. doi: 10.1097/IJG.0000000000001670. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean Retinal Sensitivity From Two Machines | Mean (Average) retinal sensitivity to light as measured in decibels in multiple spots across the central and peripheral retina (entire visual field). Higher numbers translate to dimmer light which when detected means better vision. | three hours | |
Primary | Global Correlation (Agreement Between Two Machines in the Overall Visual Field) | Correlation (Agreement) between Humphrey Visual Field and VisuALL retinal sensitivity as measured by mean deviation (light measurement in decibels) in multiple spots across the central and peripheral retina (entire visual field). This is the amount of agreement of the measure threshold, which is the lowest level of light detected in different points across the visual field (overall), between two testing machines. | three hours | |
Secondary | Inferior Nasal Quadrant Correlation (Agreement Between Two Machines in the Inferior Nasal Visual Field) | Correlation (Agreement) between Humphrey Visual Field and VisuALL retinal sensitivity as measured by mean deviation (light measurement in decibels) in multiple spots across the inferior nasal visual field. This is the amount of agreement of the measure threshold, which is the lowest level of light detected in different points across the inferior (lower) nasal portion of the visual field, between two testing machines. | three hours | |
Secondary | Superior Hemifield Correlation (Agreement Between Two Machines in the Superior Hemifield Visual Field | Correlation (Agreement) between Humphrey Visual Field and VisuALL retinal sensitivity as measured by mean deviation (light measurement in decibels) in multiple spots across the superior (upper) hemifield portion of the visual field. This is the amount of agreement of the measure threshold, which is the lowest level of light detected in different points across the visual field in the superior hemifield, between two testing machines. | three hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05044793 -
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
|
||
Recruiting |
NCT06201455 -
Evaluation of Phacogoniotomy in Medically-controlled POAG
|
N/A | |
Recruiting |
NCT03369886 -
The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI
|
N/A | |
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Recruiting |
NCT02679482 -
Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma
|
N/A | |
Completed |
NCT02338362 -
Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma
|
Phase 4 | |
Active, not recruiting |
NCT01430923 -
Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost
|
N/A | |
Completed |
NCT01489670 -
Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
|
N/A | |
Completed |
NCT00693485 -
Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy
|
Phase 2 | |
Completed |
NCT00753168 -
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
|
Phase 1/Phase 2 | |
Completed |
NCT00051194 -
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
|
Phase 2 | |
Recruiting |
NCT04920227 -
Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma
|
N/A | |
Active, not recruiting |
NCT03868124 -
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
|
Phase 3 | |
Completed |
NCT03267862 -
Scleral Response to Intraocular Pressure (IOP)
|
N/A | |
Recruiting |
NCT06066645 -
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
|
Phase 3 | |
Recruiting |
NCT04912362 -
The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma
|
N/A | |
Completed |
NCT04949802 -
Glaucoma Surgery Using the ViaLase Laser System
|
N/A | |
Recruiting |
NCT04038034 -
Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma
|
N/A | |
Completed |
NCT04632329 -
Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma
|
N/A | |
Completed |
NCT01215786 -
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
|
Phase 1 |